scholarly article | Q13442814 |
P50 | author | Neil Caporaso | Q107095573 |
P2093 | author name string | Margaret R Spitz | |
Thomas A Sellers | |||
P2860 | cites work | Opportunities and barriers in the age of team science: strategies for success | Q36401483 |
Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer | Q37194147 | ||
Invited commentary: from genome-wide association studies to gene-environment-wide interaction studies--challenges and opportunities | Q37306204 | ||
Uncovering the roles of rare variants in common disease through whole-genome sequencing | Q37755970 | ||
Bigger, better, sooner--scaling up for success | Q39646776 | ||
Molecular cancer epidemiology: a new tool in cancer prevention | Q41327207 | ||
Population-based and family-based designs to analyze rare variants in complex diseases | Q41886407 | ||
Landmarks in the history of cancer epidemiology | Q43464532 | ||
Epidemiology faces its limits. | Q52877590 | ||
Integrative study designs--next step in the evolution of molecular epidemiology? | Q79986196 | ||
The beginning of the end for the epidemiologic focus on gene-environment interactions? | Q83994654 | ||
An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus | Q21136362 | ||
Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science | Q24289208 | ||
Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology | Q24622814 | ||
Radiomics: the process and the challenges | Q26865378 | ||
Epigenome-wide association studies for common human diseases | Q28710498 | ||
Systematic identification of genomic markers of drug sensitivity in cancer cells | Q29547695 | ||
T (brachyury) gene duplication confers major susceptibility to familial chordoma | Q33273533 | ||
Can genes for mammographic density inform cancer aetiology? | Q33635885 | ||
Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement | Q33851304 | ||
Gene--environment-wide association studies: emerging approaches | Q33937986 | ||
Next generation analytic tools for large scale genetic epidemiology studies of complex diseases | Q34029677 | ||
STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement | Q34062156 | ||
The Emergence of Translational Epidemiology: From Scientific Discovery to Population Health Impact | Q34082166 | ||
A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment | Q35581883 | ||
Integrative epidemiology: from risk assessment to outcome prediction | Q36002142 | ||
Frontiers in cancer epidemiology: a challenge to the research community from the Epidemiology and Genomics Research Program at the National Cancer Institute | Q36083974 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | epidemiology | Q133805 |
P304 | page(s) | 1087-90 | |
P577 | publication date | 2012-12-01 | |
P1433 | published in | Cancer Discovery | Q15724440 |
P1476 | title | Integrative cancer epidemiology--the next generation | |
P478 | volume | 2 |
Q38743221 | Association of breast cancer risk and the mTOR pathway in women of African ancestry in 'The Root' Consortium |
Q40580231 | Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer |
Q36819754 | Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: a multilevel approach |
Q24658639 | Charting a future for epidemiologic training |
Q27011884 | Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology |
Q35098158 | Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France |
Q26852716 | Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression |
Q36463854 | Integration of molecular pathology, epidemiology and social science for global precision medicine |
Q37075412 | Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication |
Q24289344 | Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease |
Q37172368 | Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. |
Q36926941 | Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer |
Q37360360 | Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. |
Q34475686 | Proceedings of the second international molecular pathological epidemiology (MPE) meeting |
Q34016833 | Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions |
Q36410322 | Provocative questions in cancer epidemiology in a time of scientific innovation and budgetary constraints |
Q36968401 | Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine |
Q24289206 | The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists |
Q28072100 | Transdisciplinary approaches enhance the production of translational knowledge |
Q24289006 | Transforming Epidemiology for 21st Century Medicine and Public Health |
Q45997237 | Why precursors matter. |
Search more.